HESTER BIOSCIENCES Financial Statement Analysis
|
||
|
The Revenues of HESTER BIOSCIENCES have increased by 9.65% YoY .
The Earnings Per Share (EPS) of HESTER BIOSCIENCES has decreased by -32.28 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
HESTER BIOSCIENCES Last 5 Annual Financial Results
[BOM: 524669|NSE : HESTERBIO]
| Consolidated | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
|---|---|---|---|---|---|
| Revenues | ₹235 Cr | ₹214 Cr | ₹183 Cr | ₹178,066,773 Cr | ₹136 Cr |
| Expenses | ₹175 Cr | ₹146 Cr | ₹128 Cr | ₹110,031,714 Cr | ₹89 Cr |
| Operating Profit (Excl OI) | ₹60 Cr | ₹69 Cr | ₹55 Cr | ₹68,035,059 Cr | ₹47 Cr |
| Other Income | ₹14 Cr | ₹4.68 Cr | ₹6.37 Cr | ₹7,210,277 Cr | ₹2.55 Cr |
| Interest | ₹4.06 Cr | ₹6.60 Cr | ₹7.37 Cr | ₹6,633,889 Cr | ₹4.04 Cr |
| Depreciation | ₹17 Cr | ₹13 Cr | ₹13 Cr | ₹11,755,368 Cr | ₹9.66 Cr |
| Profit Before Tax | ₹54 Cr | ₹50 Cr | ₹41 Cr | ₹56,856,079 Cr | ₹36 Cr |
| Profit After Tax | ₹39 Cr | ₹35 Cr | ₹31 Cr | ₹40,693,598 Cr | ₹23 Cr |
| Consolidated Net Profit | ₹39 Cr | ₹34 Cr | ₹29 Cr | ₹41,567,332 Cr | ₹26 Cr |
| Earnings Per Share (Rs) | ₹31.30 | ₹46.22 | ₹40.47 | ₹34.29 | ₹48.86 |
| PAT Margin (%) | 10.46 | 16.67 | 16.16 | 16.92 | 22.85 |
| ROE(%) | 10.39 | 16.17 | 16.16 | 16.38 | 25.59 |
| ROCE(%) | 9.60 | 14.12 | 17.33 | 16.53 | 26.64 |
| Total Debt/Equity(x) | 0.96 | 0.86 | 0.46 | 0.60 | 0.51 |
Key Financials |
||
| Market Cap | : | ₹ 1,347.3 Cr |
| Revenue (TTM) | : | ₹ 292.6 Cr |
| Net Profit(TTM) | : | ₹ 16.1 Cr |
| EPS (TTM) | : | ₹ 18.9 |
| P/E (TTM) | : | 83.9 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| HESTER BIOSCIENCES | 0.9% | -1.5% | -17.9% |
| SUN PHARMACEUTICAL INDUSTRIES | 3% | 2.3% | 68.2% |
| CIPLA | 2.5% | 0.4% | 71.7% |
| DR REDDYS LABORATORIES | -0.2% | -4.9% | 40.3% |
| ZYDUS LIFESCIENCES | 5% | 10.4% | 109.1% |
| DIVIS LABORATORIES | -1.6% | -7% | 23.8% |
| MANKIND PHARMA | NA | NA | NA |
| TORRENT PHARMACEUTICALS | 2.9% | -2.2% | 69% |
| LUPIN | 2.8% | 0% | 147.8% |
HESTER BIOSCIENCES Revenues
[BOM: 524669|NSE : HESTERBIO]
| Y-o-Y | 9.65 % |
| 5 Yr CAGR | 14.67 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2023 | ₹235 Cr | 9.65 | |
| Mar2022 | ₹214 Cr | 16.95 | |
| Mar2021 | ₹183 Cr | -100.00 | |
| Mar2020 | ₹178,066,773 Cr | 130,990,103.84 | |
| Mar2019 | ₹136 Cr | - | |
HESTER BIOSCIENCES Operating Profit
[BOM: 524669|NSE : HESTERBIO]
| Y-o-Y | -12.64 % |
| 5 Yr CAGR | 6.14 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2023 | ₹60 Cr | -12.64 | |
| Mar2022 | ₹69 Cr | 23.93 | |
| Mar2021 | ₹55 Cr | -100.00 | |
| Mar2020 | ₹68,035,059 Cr | 143,949,837.79 | |
| Mar2019 | ₹47 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | -20.32 % |
| 5 Yr CAGR | -7.44 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2023 | 25.52% | -20.32 | |
| Mar2022 | 32.03% | 5.95 | |
| Mar2021 | 30.23% | -20.88 | |
| Mar2020 | 38.21% | 9.89 | |
| Mar2019 | 34.77% | - | |
HESTER BIOSCIENCES Profit After Tax
[BOM: 524669|NSE : HESTERBIO]
| Y-o-Y | 14.20 % |
| 5 Yr CAGR | 11.30 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2023 | ₹39 Cr | 14.20 | |
| Mar2022 | ₹34 Cr | 18.03 | |
| Mar2021 | ₹29 Cr | -100.00 | |
| Mar2020 | ₹41,567,332 Cr | 162,239,202.13 | |
| Mar2019 | ₹26 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -37.25 % |
| 5 Yr CAGR | -17.75 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2023 | 10.46 % | -37.25 | |
| Mar2022 | 16.67 % | 3.16 | |
| Mar2021 | 16.16 % | -4.49 | |
| Mar2020 | 16.92 % | -25.95 | |
| Mar2019 | 22.85 % | - | |
HESTER BIOSCIENCES Earnings Per Share (EPS)
[BOM: 524669|NSE : HESTERBIO]
| Y-o-Y | -32.28 % |
| 5 Yr CAGR | -10.54 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2023 | ₹31 | -32.28 | |
| Mar2022 | ₹46 | 14.21 | |
| Mar2021 | ₹40 | 18.02 | |
| Mar2020 | ₹34 | -29.82 | |
| Mar2019 | ₹49 | - | |
HESTER BIOSCIENCES Return on Capital Employed (ROCE)
[BOM: 524669|NSE : HESTERBIO]
| Y-o-Y | -32.01 % |
| 5 Yr CAGR | -22.52 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2023 | 9.6% | -32.01 | |
| Mar2022 | 14.12% | -18.52 | |
| Mar2021 | 17.33% | 4.84 | |
| Mar2020 | 16.53% | -37.95 | |
| Mar2019 | 26.64% | - | |
HESTER BIOSCIENCES Share Price vs Sensex
| Current Share Price | : | ₹1,585.1 |
| Current MarketCap | : | ₹ 1,347.3 Cr |
| Updated EOD on | : | Apr 15,2024 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HESTER BIOSCIENCES | 0.9% |
-1.5% |
-17.9% |
| SENSEX | -1.1% |
-0.1% |
22.7% |
HESTER BIOSCIENCES related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| S&P BSE ALLCAP | -1.2% | 1% | 39.4% |
| S&P BSE MIDSMALLCAP | -1.6% | 2.3% | 63.6% |
| S&P BSE HEALTHCARE | -1.9% | -0.1% | 56.2% |
| S&P BSE SMALL CAP | -1.9% | 3.2% | 62.6% |
No NSE index found
You may also like the below Video Courses
FAQ about HESTER BIOSCIENCES Financials
How the annual revenues of HESTER BIOSCIENCES have changed ?
The Revenues of HESTER BIOSCIENCES have increased by 9.65% YoY .
How the Earnings per Share (EPS) of HESTER BIOSCIENCES have changed?
The Earnings Per Share (EPS) of HESTER BIOSCIENCES has decreased by -32.28 % YoY .
Check out Intrinsic Value of Peers of HESTER BIOSCIENCES
Compare Stock Analytics of Peers of HESTER BIOSCIENCES
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
